Transcriptional Corepressors HIPK1 and HIPK2 Control Angiogenesis Via TGF-β-TAK1-Dependent Mechanism

PLoS Biology

Volumn 11, Issue 4, 2013, Pages

  Shang, Yulei ^a,b   Doan, Christina N ^a,b   Arnold, Thomas D ^a,c   Lee, Sebum ^a,b   Tang, Amy A ^a,b   Reichardt, Louis F ^c   Huang, Eric J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COREPRESSOR PROTEIN; HIPK1 PROTEIN; HOMEODOMAIN INTERACTING PROTEIN KINASE 2; HOMEODOMAIN PROTEIN; PROTEIN KINASE; SMALL INTERFERING RNA; STROMELYSIN 2; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TYROSINE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL AGGREGATION; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; COMPLEX FORMATION; EMBRYO; EMBRYO DEVELOPMENT; HEMANGIOBLAST; MOUSE; NONHUMAN; PHENOTYPE; POINT MUTATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; YOLK SAC;

ADHERENS JUNCTIONS; AMINO ACID SEQUENCE; ANIMALS; CARRIER PROTEINS; CELL PROLIFERATION; CONSERVED SEQUENCE; EMBRYONIC DEVELOPMENT; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEK293 CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MADS DOMAIN PROTEINS; MAP KINASE KINASE KINASES; MATRIX METALLOPROTEINASE 10; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; MYOGENIC REGULATORY FACTORS; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHORYLATION; PROTEIN INTERACTION MAPPING; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN-SERINE-THREONINE KINASES; PROTEOLYSIS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84876961787     PISSN: 15449173     EISSN: 15457885     Source Type: Journal    
DOI: 10.1371/journal.pbio.1001527     Document Type: Article

References (47)

1. Carmeliet P, (2005) Angiogenesis in life, disease and medicine. Nature 438: 932-936.
2. Rossant J, Howard L, (2002) Signaling pathways in vascular development. Annual Review of Cell and Developmental Biology 18: 541-573.
3. Coultas L, Chawengsaksophak K, Rossant J, (2005) Endothelial cells and VEGF in vascular development. Nature 438: 937-945.
4. You LR, Lin FJ, Lee CT, DeMayo FJ, Tsai MJ, et al. (2005) Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity. Nature 435: 98-104.
5. Qin J, Chen X, Xie X, Tsai MJ, Tsai SY, (2010) COUP-TFII regulates tumor growth and metastasis by modulating tumor angiogenesis. Proc Natl Acad Sci U S A 107: 3687-3692.
6. Massague J, Blain SW, Lo RS, (2000) TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 103: 295-309.
7. Pardali E, Goumans MJ, ten Dijke P, (2010) Signaling by members of the TGF-beta family in vascular morphogenesis and disease. Trends Cell Biol 20: 556-567.
8. Moustakas A, Heldin CH, (2009) The regulation of TGFbeta signal transduction. Development 136: 3699-3714.
9. ten Dijke P, Arthur HM, (2007) Extracellular control of TGFbeta signalling in vascular development and disease. Nat Rev Mol Cell Biol 8: 857-869.
10. Goumans MJ, Valdimarsdottir G, Itoh S, Lebrin F, Larsson J, et al. (2003) Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. Mol Cell 12: 817-828.
11. Goumans MJ, Valdimarsdottir G, Itoh S, Rosendahl A, Sideras P, et al. (2002) Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. EMBO J 21: 1743-1753.
12. Massague J, Seoane J, Wotton D, (2005) Smad transcription factors. Genes Dev 19: 2783-2810.
13. Zhang J, Pho V, Bonasera SJ, Holzmann J, Tang AT, et al. (2007) Essential function of HIPK2 in TGFbeta-dependent survival of midbrain dopamine neurons. Nat Neurosci 10: 77-86.
14. Chalazonitis A, Tang AA, Shang Y, Pham TD, Hsieh I, et al. (2011) Homeodomain interacting protein kinase 2 regulates postnatal development of enteric dopaminergic neurons and glia via BMP signaling. J Neurosci 31: 13746-13757.
15. Harada J, Kokura K, Kanei-Ishii C, Nomura T, Khan MM, et al. (2003) Requirement of the co-repressor homeodomain-interacting protein kinase 2 for ski-mediated inhibition of bone morphogenetic protein-induced transcriptional activation. J Biol Chem 278: 38998-39005.
16. Hofmann TG, Stollberg N, Schmitz ML, Will H, (2003) HIPK2 regulates transforming growth factor-beta-induced c-Jun NH(2)-terminal kinase activation and apoptosis in human hepatoma cells. Cancer Res 63: 8271-8277.
17. Jin Y, Ratnam K, Chuang PY, Fan Y, Zhong Y, et al. (2012) A systems approach identifies HIPK2 as a key regulator of kidney fibrosis. Nature Medicine 18: 580-588.
18. Kondo S, Lu Y, Debbas M, Lin AW, Sarosi I, et al. (2003) Characterization of cells and gene-targeted mice deficient for the p53-binding kinase homeodomain-interacting protein kinase 1 (HIPK1). Proc Natl Acad Sci U S A 100: 5431-5436.
19. Isono K, Nemoto K, Li Y, Takada Y, Suzuki R, et al. (2006) Overlapping roles for homeodomain-interacting protein kinases hipk1 and hipk2 in the mediation of cell growth in response to morphogenetic and genotoxic signals. Mol Cell Biol 26: 2758-2771.
20. Aikawa Y, Nguyen LA, Isono K, Takakura N, Tagata Y, et al. (2006) Roles of HIPK1 and HIPK2 in AML1- and p300-dependent transcription, hematopoiesis and blood vessel formation. EMBO J 25: 3955-3965.
21. Bajou K, Masson V, Gerard RD, Schmitt PM, Albert V, et al. (2001) The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies. J Cell Biol 152: 777-784.
22. Guan KL, Jenkins CW, Li Y, Nichols MA, Wu X, et al. (1994) Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev 8: 2939-2952.
23. Zariwala M, Liu J, Xiong Y, (1998) Cyclin E2, a novel human G1 cyclin and activating partner of CDK2 and CDK3, is induced by viral oncoproteins. Oncogene 17: 2787-2798.
24. Abbas T, Sivaprasad U, Terai K, Amador V, Pagano M, et al. (2008) PCNA-dependent regulation of p21 ubiquitylation and degradation via the CRL4Cdt2 ubiquitin ligase complex. Genes Dev 22: 2496-2506.
25. Chang S, Young BD, Li S, Qi X, Richardson JA, et al. (2006) Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10. Cell 126: 321-334.
26. Jadrich JL, O'Connor MB, Coucouvanis E, (2006) The TGF beta activated kinase TAK1 regulates vascular development in vivo. Development 133: 1529-1541.
27. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, et al. (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380: 435-439.
28. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, et al. (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380: 439-442.
29. Lemon B, Tjian R, (2000) Orchestrated response: a symphony of transcription factors for gene control. Genes & Development 14: 2551-2569.
30. Kanei-Ishii C, Ninomiya-Tsuji J, Tanikawa J, Nomura T, Ishitani T, et al. (2004) Wnt-1 signal induces phosphorylation and degradation of c-Myb protein via TAK1, HIPK2, and NLK. Genes Dev 18: 816-829.
31. Kurahashi T, Nomura T, Kanei-Ishii C, Shinkai Y, Ishii S, (2005) The Wnt-NLK signaling pathway inhibits A-Myb activity by inhibiting the association with coactivator CBP and methylating histone H3. Mol Biol Cell 16: 4705-4713.
32. Sorrentino A, Thakur N, Grimsby S, Marcusson A, von Bulow V, et al. (2008) The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner. Nat Cell Biol 10: 1199-1207.
33. Yamaguchi K, Shirakabe K, Shibuya H, Irie K, Oishi I, et al. (1995) Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction. Science 270: 2008-2011.
34. Yamashita M, Fatyol K, Jin C, Wang X, Liu Z, et al. (2008) TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta. Mol Cell 31: 918-924.
35. Ono K, Ohtomo T, Ninomiya-Tsuji J, Tsuchiya M, (2003) A dominant negative TAK1 inhibits cellular fibrotic responses induced by TGF-beta. Biochem Biophys Res Commun 307: 332-337.
36. Akella R, Moon TM, Goldsmith EJ, (2008) Unique MAP Kinase binding sites. Biochimica et Biophysica Acta 1784: 48-55.
37. Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, et al. (2001) Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocrine Reviews 22: 153-183.
38. Braren R, Hu H, Kim YH, Beggs HE, Reichardt LF, et al. (2006) Endothelial FAK is essential for vascular network stability, cell survival, and lamellipodial formation. J Cell Biol 172: 151-162.
39. Derynck R, Zhang YE, (2003) Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425: 577-584.
40. Gong X, Tang X, Wiedmann M, Wang X, Peng J, et al. (2003) Cdk5-mediated inhibition of the protective effects of transcription factor MEF2 in neurotoxicity-induced apoptosis. Neuron 38: 33-46.
41. Wang X, She H, Mao Z, (2009) Phosphorylation of neuronal survival factor MEF2D by glycogen synthase kinase 3beta in neuronal apoptosis. J Biol Chem 284: 32619-32626.
42. Pardali K, Kowanetz M, Heldin CH, Moustakas A, (2005) Smad pathway-specific transcriptional regulation of the cell cycle inhibitor p21(WAF1/Cip1). Journal of Cellular Physiology 204: 260-272.
43. Wiggins AK, Wei G, Doxakis E, Wong C, Tang AA, et al. (2004) Interaction of Brn3a and HIPK2 mediates transcriptional repression of sensory neuron survival. J Cell Biol 167: 257-267.
44. Proctor JM, Zang K, Wang D, Wang R, Reichardt LF, (2005) Vascular development of the brain requires beta8 integrin expression in the neuroepithelium. J Neurosci 25: 9940-9948.
45. Chytil A, Magnuson MA, Wright CV, Moses HL, (2002) Conditional inactivation of the TGF-beta type II receptor using Cre:Lox. Genesis 32: 73-75.
46. Jones EA, Yuan L, Breant C, Watts RJ, Eichmann A, (2008) Separating genetic and hemodynamic defects in neuropilin 1 knockout embryos. Development 135: 2479-2488.
47. Wei G, Ku S, Ma GK, Saito S, Tang AA, et al. (2007) HIPK2 represses beta-catenin-mediated transcription, epidermal stem cell expansion, and skin tumorigenesis. Proc Natl Acad Sci U S A 104: 13040-13045.